Cadila Healthcare
-
{
- All
- News
- Videos
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
Cadila Healthcare Starts Producing COVID-19 Vaccine Candidate
Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
Zydus Cadila Gets USFDA Nod To Drug That Treats Severe Acne Vulgaris
Zydus Pharmaceuticals has received the final approval from the USFDA to market Minocycline Hydrochloride Extended Release Tablets
-
Cadila Gets USFDA's Final Nod To Market Ethacrynate Sodium
Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
-
Billionaire Father, Son Turn 10-Storey Mumbai Office Into World Beater
Cadila's stock delivered returns of almost 50 percent, making it the best among generic drugmakers worldwide with a market value of more than $1 billion.
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
Cadila Healthcare Starts Producing COVID-19 Vaccine Candidate
Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
Zydus Cadila Gets USFDA Nod To Drug That Treats Severe Acne Vulgaris
Zydus Pharmaceuticals has received the final approval from the USFDA to market Minocycline Hydrochloride Extended Release Tablets
-
Cadila Gets USFDA's Final Nod To Market Ethacrynate Sodium
Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
-
Billionaire Father, Son Turn 10-Storey Mumbai Office Into World Beater
Cadila's stock delivered returns of almost 50 percent, making it the best among generic drugmakers worldwide with a market value of more than $1 billion.
